These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study. Barbaro G; Di Lorenzo G; Soldini M; Marziali M; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Barbarini G Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248 [TBL] [Abstract][Full Text] [Related]
26. Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil. Ferenci P; Grimm G; Meryn S; Gangl A Gastroenterology; 1989 Jan; 96(1):240-3. PubMed ID: 2491822 [TBL] [Abstract][Full Text] [Related]
27. The visual evoked potential in clinical hepatic encephalopathy in acute and chronic liver disease. Levy LJ; Bolton RP; Losowsky MS Hepatogastroenterology; 1990 Dec; 37 Suppl 2():66-73. PubMed ID: 2083938 [TBL] [Abstract][Full Text] [Related]
28. Is flumazenil an alternative for the treatment of hepatic encephalopathy? Reyes D; Barrera F Medwave; 2017 Dec; 17(9):e7113. PubMed ID: 29286356 [TBL] [Abstract][Full Text] [Related]
30. [New concepts in the physiopathology of hepatic encephalopathy and therapeutic prospects]. Romero Gómez M; Bautista JD; Grande L; Ramos Guerrero RM; Sánchez Muñoz D Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():40-8. PubMed ID: 15195533 [No Abstract] [Full Text] [Related]
31. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study. Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999 [TBL] [Abstract][Full Text] [Related]
32. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850 [TBL] [Abstract][Full Text] [Related]
33. Flumazenil in the treatment of portal systemic encephalopathy--an overview. Gyr K; Meier R Intensive Care Med; 1991; 17 Suppl 1():S39-42. PubMed ID: 1774410 [TBL] [Abstract][Full Text] [Related]
34. [GABA-benzodiazepine receptor complex: therapeutic role of benzodiazepine antagonists]. Andresen M; Arrese M; Dougnac A; Godoy J; Prat G; Chianale J Rev Med Chil; 1989 Aug; 117(8):944-6. PubMed ID: 2562414 [No Abstract] [Full Text] [Related]
35. Flumazenil: potential implications for hepatic encephalopathy. Jones EA; Basile AS; Mullen KD; Gammal SH Pharmacol Ther; 1990; 45(3):331-43. PubMed ID: 2105510 [No Abstract] [Full Text] [Related]
36. [Treatment of hepatic encephalopathy with flumazenil]. Marsepoil T; Hermant JL; Ho P; Blin F; Levesque P Ann Fr Anesth Reanim; 1990; 9(4):399-400. PubMed ID: 2119158 [No Abstract] [Full Text] [Related]